Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT DOSES IN FINLAND.

Järvinen J, Sierpowska J, Siiskonen T, Järvinen H, Kiviniemi T, Rissanen TT, Matikka H, Niskanen E, Hurme S, Larjava HRS, Mäkelä TJ, Strengell S, Eskola M, Parviainen T, Hallinen E, Pirinen M, Kivelä A, Teräs M.

Radiat Prot Dosimetry. 2019 Apr 16. pii: ncz041. doi: 10.1093/rpd/ncz041. [Epub ahead of print]

PMID:
30989216
2.

Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open-Heart Operations.

Lehto J, Kiviniemi T, Gunn J, Airaksinen J, Rautava P, Kytö V.

J Am Heart Assoc. 2018 Nov 20;7(22):e010269. doi: 10.1161/JAHA.118.010269.

3.

Preoperative Myocardial Troponin T Elevation is Associated with the Fracture Type in Patients with Proximal Femoral Fracture.

Nordling P, Strandberg M, Strandberg NNG, Kiviniemi TO, Mäkelä KT, Airaksinen KEJ.

Scand J Surg. 2018 Dec 6:1457496918816928. doi: 10.1177/1457496918816928. [Epub ahead of print]

PMID:
30520365
4.

Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?

Jaakkola S, Kiviniemi TO, Airaksinen KEJ.

Ann Med. 2018 Nov;50(7):549-555. doi: 10.1080/07853890.2018.1523552. Epub 2018 Oct 15.

PMID:
30207497
5.

Performance of CHA2DS2-VASc score for stroke prediction after surgical aortic valve replacement.

Kiviniemi T, Lehto J, Nissinen M, Nieminen T, Hartikainen J, Malmberg M, Yannopoulos F, Savolainen J, Karjalainen P, Airaksinen KEJ, Rosato S, Biancari F.

J Thorac Cardiovasc Surg. 2018 Jul 29. pii: S0022-5223(18)32030-0. doi: 10.1016/j.jtcvs.2018.06.096. [Epub ahead of print]

PMID:
30174132
6.

Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin.

Lehtola H, Palomäki A, Mustonen P, Hartikainen P, Kiviniemi T, Sallinen H, Nuotio I, Ylitalo A, Airaksinen KEJ, Hartikainen J.

Neurol Clin Pract. 2018 Aug;8(4):311-317. doi: 10.1212/CPJ.0000000000000491.

PMID:
30140582
7.

Multiclass Classifier based Cardiovascular Condition Detection Using Smartphone Mechanocardiography.

Iftikhar Z, Lahdenoja O, Jafari Tadi M, Hurnanen T, Vasankari T, Kiviniemi T, Airaksinen J, Koivisto T, Pänkäälä M.

Sci Rep. 2018 Jun 19;8(1):9344. doi: 10.1038/s41598-018-27683-9.

8.

Optimal timing for cardioversion in patients with atrial fibrillation.

Hellman T, Kiviniemi T, Nuotio I, Biancari F, Vasankari T, Hartikainen J, Lehto M, Airaksinen KE; FinCV Investigators.

Clin Cardiol. 2018 Jul;41(7):966-971. doi: 10.1002/clc.22986. Epub 2018 Jul 23.

9.

How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

Lehtola H, Hartikainen J, Hartikainen P, Kiviniemi T, Nuotio I, Palomäki A, Ylitalo A, Airaksinen KEJ, Mustonen P.

Clin Cardiol. 2018 May;41(5):608-614. doi: 10.1002/clc.22935. Epub 2018 May 10.

10.

Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting.

Nammas W, Dalén M, Rosato S, Gherli R, Reichart D, Gatti G, Onorati F, Faggian G, De Feo M, Bancone C, Chocron S, Khodabandeh S, Santarpino G, Rubino AS, Maselli D, Nardella S, Salsano A, Gherli T, Nicolini F, Zanobini M, Saccocci M, Bounader K, D'Errigo P, Kiviniemi T, Kinnunen EM, Perrotti A, Airaksinen J, Mariscalco G, Ruggieri VG, Biancari F.

Platelets. 2019;30(4):480-486. doi: 10.1080/09537104.2018.1466389. Epub 2018 Apr 20.

PMID:
29676943
11.

Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).

Jaakkola J, Jaakkola S, Lahdenoja O, Hurnanen T, Koivisto T, Pänkäälä M, Knuutila T, Kiviniemi TO, Vasankari T, Airaksinen KEJ.

Circulation. 2018 Apr 3;137(14):1524-1527. doi: 10.1161/CIRCULATIONAHA.117.032804. Epub 2018 Mar 11. No abstract available.

PMID:
29526834
12.

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).

Jaakkola S, Kiviniemi TO, Nuotio I, Hartikainen J, Mustonen P, Palomäki A, Jaakkola J, Ylitalo A, Hartikainen P, Airaksinen KEJ.

Am J Cardiol. 2018 May 15;121(10):1182-1186. doi: 10.1016/j.amjcard.2018.01.038. Epub 2018 Feb 12.

PMID:
29526276
13.

Determinants of re-operation for bleeding in head and neck cancer surgery.

Haapio E, Kinnunen I, Airaksinen JKE, Irjala H, Kiviniemi T.

J Laryngol Otol. 2018 Apr;132(4):336-340. doi: 10.1017/S0022215118000294. Epub 2018 Mar 8.

PMID:
29517474
14.

Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement.

Kiviniemi T, Malmberg M, Biancari F, Hartikainen J, Ihlberg L, Yannopoulos F, Riekkinen T, von Hellens O, Lehto J, Nissinen M, Airaksinen KJ, Nieminen T.

Eur Heart J Qual Care Clin Outcomes. 2018 Apr 1;4(2):120-125. doi: 10.1093/ehjqcco/qcy003.

PMID:
29390053
15.

Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery.

Biancari F, Kinnunen EM, Kiviniemi T, Tauriainen T, Anttila V, Airaksinen JKE, Brascia D, Vasques F.

J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1618-1624. doi: 10.1053/j.jvca.2017.12.024. Epub 2017 Dec 13.

PMID:
29338997
16.

Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.

Nammas W, Kiviniemi T, Schlitt A, Rubboli A, Valencia J, Lip GYH, Karjalainen PP, Biancari F, Juhani Airaksinen KE.

Int J Cardiol. 2018 Feb 15;253:35-39. doi: 10.1016/j.ijcard.2017.07.074.

PMID:
29306469
17.

Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Lahtela HM, Bah A, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Karjalainen PP, Proietti M, Hartikainen JEK, Lip GYH, Airaksinen KEJ.

Clin Cardiol. 2017 Dec;40(12):1264-1270. doi: 10.1002/clc.22821. Epub 2017 Dec 15.

18.

Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish CVD register.

Myllykangas ME, Aittokallio JM, Pietilä A, Salomaa VV, Gunn JM, Kiviniemi TO, Niiranen TJ.

Scand Cardiovasc J. 2018 Feb;52(1):51-57. doi: 10.1080/14017431.2017.1405068. Epub 2017 Dec 3.

PMID:
29198154
19.

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Virta A, Airaksinen KEJ.

Ann Med. 2018 Mar;50(2):164-171. doi: 10.1080/07853890.2017.1407494. Epub 2017 Nov 23.

PMID:
29156997
20.

Transfusion and blood stream infections after coronary surgery.

Tauriainen T, Kinnunen EM, Laitinen I, Anttila V, Kiviniemi T, Airaksinen JKE, Biancari F.

Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):325-327. doi: 10.1093/icvts/ivx320.

PMID:
29049748
21.

Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).

Lautamäki A, Gunn JM, Airaksinen KEJ, Biancari F, Kajander OA, Anttila V, Heikkinen J, Eskola M, Ilveskoski E, Mennander A, Korpilahti K, Wistbacka JO, Kiviniemi TO.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):101-106. doi: 10.1093/ehjqcco/qcw043.

PMID:
28927176
22.

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GY; AFCAS Study Group.

Am Heart J. 2017 Aug;190:86-93. doi: 10.1016/j.ahj.2017.05.016. Epub 2017 Jun 3.

PMID:
28760217
23.

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.

Hellman T, Kiviniemi T, Nuotio I, Vasankari T, Hartikainen J, Lip GYH, Airaksinen KEJ.

Thromb Res. 2017 Aug;156:163-167. doi: 10.1016/j.thromres.2017.06.026. Epub 2017 Jun 22.

PMID:
28662483
24.

Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography.

Grönman M, Tarkia M, Kiviniemi T, Halonen P, Kuivanen A, Savunen T, Tolvanen T, Teuho J, Käkelä M, Metsälä O, Pietilä M, Saukko P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A.

J Transl Med. 2017 Jun 19;15(1):144. doi: 10.1186/s12967-017-1245-1.

25.

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Issakoff M, Airaksinen KEJ.

PLoS One. 2017 Apr 20;12(4):e0175975. doi: 10.1371/journal.pone.0175975. eCollection 2017.

26.

Atrial Fibrillation Detection via Accelerometer and Gyroscope of a Smartphone.

Lahdenoja O, Hurnanen T, Iftikhar Z, Nieminen S, Knuutila T, Saraste A, Kiviniemi T, Vasankari T, Airaksinen J, Pankaala M, Koivisto T.

IEEE J Biomed Health Inform. 2018 Jan;22(1):108-118. doi: 10.1109/JBHI.2017.2688473. Epub 2017 Apr 5.

PMID:
28391210
27.

Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.

Lehtola H, Airaksinen KEJ, Hartikainen P, Hartikainen JEK, Palomäki A, Nuotio I, Ylitalo A, Kiviniemi T, Mustonen P.

Eur J Neurol. 2017 May;24(5):719-725. doi: 10.1111/ene.13280. Epub 2017 Mar 20.

PMID:
28317289
28.

Detection of atrial fibrillation with seismocardiography.

Pankaala M, Koivisto T, Lahdenoja O, Kiviniemi T, Saraste A, Vasankari T, Airaksinen J.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4369-4374. doi: 10.1109/EMBC.2016.7591695.

PMID:
28269246
29.

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.

Hellman T, Kiviniemi T, Vasankari T, Nuotio I, Biancari F, Bah A, Hartikainen J, Mäkäräinen M, Airaksinen KE.

BMC Cardiovasc Disord. 2017 Jan 18;17(1):33. doi: 10.1186/s12872-017-0470-0.

30.

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GYH; AFCAS Study Group.

Clin Res Cardiol. 2017 Jun;106(6):420-427. doi: 10.1007/s00392-016-1071-0. Epub 2017 Jan 11.

31.

Stroke as the First Manifestation of Atrial Fibrillation.

Jaakkola J, Mustonen P, Kiviniemi T, Hartikainen JE, Palomäki A, Hartikainen P, Nuotio I, Ylitalo A, Airaksinen KE.

PLoS One. 2016 Dec 9;11(12):e0168010. doi: 10.1371/journal.pone.0168010. eCollection 2016.

32.

Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.

Varho V, Nammas W, Kiviniemi TO, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Karjalainen PP.

Int J Cardiol. 2017 Jan 15;227:194-200. doi: 10.1016/j.ijcard.2016.11.173. Epub 2016 Nov 9.

PMID:
27839810
33.

Automated Detection of Atrial Fibrillation Based on Time-Frequency Analysis of Seismocardiograms.

Hurnanen T, Lehtonen E, Tadi MJ, Kuusela T, Kiviniemi T, Saraste A, Vasankari T, Airaksinen J, Koivisto T, Pankaala M.

IEEE J Biomed Health Inform. 2017 Sep;21(5):1233-1241. doi: 10.1109/JBHI.2016.2621887. Epub 2016 Nov 4.

PMID:
27834656
34.

Trends in rates, patient selection and prognosis of coronary revascularisations in Finland between 1994 and 2013: the CVDR.

Kiviniemi TO, Pietilä A, Gunn JM, Aittokallio JM, Mähönen MS, Salomaa VV, Niiranen TJ.

EuroIntervention. 2016 Oct 20;12(9):1117-1125. doi: 10.4244/EIJV12I9A183.

35.

Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.

Palomäki A, Kiviniemi T, Mustonen P, Odei C, Hartikainen JEK, Nuotio I, Ylitalo A, Hartikainen P, Biancari F, Airaksinen KEJ.

Int J Cardiol. 2017 Jan 15;227:869-874. doi: 10.1016/j.ijcard.2016.06.107. Epub 2016 Jun 23.

PMID:
27639597
36.

Incidence and predictors of 30-day cardiovascular complications in patients undergoing head and neck cancer surgery.

Haapio E, Kiviniemi T, Irjala H, Koivunen P, Airaksinen JKE, Kinnunen I.

Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4601-4606. doi: 10.1007/s00405-016-4164-5. Epub 2016 Jul 4.

PMID:
27376645
37.

Excessive intravenous fluid therapy in head and neck cancer surgery.

Haapio E, Kinnunen I, Airaksinen JK, Irjala H, Kiviniemi T.

Head Neck. 2017 Jan;39(1):37-41. doi: 10.1002/hed.24525. Epub 2016 Jun 14.

PMID:
27299857
38.

Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

Palomäki A, Kiviniemi T, Hartikainen JE, Mustonen P, Ylitalo A, Nuotio I, Hartikainen P, Jaakkola J, Luite R, Airaksinen KE.

Clin Cardiol. 2016 Aug;39(8):471-6. doi: 10.1002/clc.22554. Epub 2016 May 30.

39.

Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.

Varho V, Kiviniemi TO, Nammas W, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Mikkelsson J, Tuomainen P, Perälä A, Karjalainen PP.

Int J Cardiovasc Imaging. 2016 Jul;32(7):1031-9. doi: 10.1007/s10554-016-0871-7. Epub 2016 Apr 13.

PMID:
27076220
40.

Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.

Nordling P, Kiviniemi T, Strandberg M, Strandberg N, Airaksinen J.

BMJ Open. 2016 Feb 24;6(2):e009416. doi: 10.1136/bmjopen-2015-009416.

41.

Occurrence of postpericardiotomy syndrome admissions: A population-based registry study.

Lehto J, Kiviniemi TO, Gunn J, Mustonen P, Airaksinen J, Biancari F, Rautava P, Sipilä J, Kytö V.

Ann Med. 2016;48(1-2):28-33. doi: 10.3109/07853890.2015.1122223. Epub 2015 Dec 15.

PMID:
26671291
42.

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Lehtola H, Luite R, Airaksinen KE.

Int J Cardiol. 2016 Jan 15;203:269-73. doi: 10.1016/j.ijcard.2015.10.168. Epub 2015 Oct 20.

PMID:
26519683
43.

Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Airaksinen KE.

Eur J Neurol. 2016 Jan;23(1):133-9. doi: 10.1111/ene.12820. Epub 2015 Aug 11.

PMID:
26263442
44.

Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.

Lautamäki A, Kiviniemi T, Biancari F, Airaksinen J, Juvonen T, Gunn J.

Eur J Cardiothorac Surg. 2016 Mar;49(3):926-30. doi: 10.1093/ejcts/ezv233. Epub 2015 Jul 4.

PMID:
26142469
45.

Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention.

Gunn J, Kiviniemi T, Biancari F, Kajander O, Mäkikallio T, Eskola M, Ilveskoski E, Korpilahti K, Wistbacka JO, Anttila V, Heikkinen J, Airaksinen J.

Scand J Work Environ Health. 2015 Sep 1;41(5):460-6. doi: 10.5271/sjweh.3508. Epub 2015 Jun 17.

46.

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.

Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, Rubboli A, Ylitalo A, Valencia J, Lip GY, Airaksinen KE.

PLoS One. 2015 Jun 1;10(6):e0128492. doi: 10.1371/journal.pone.0128492. eCollection 2015.

47.

Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.

Jaakkola J, Hartikainen JE, Kiviniemi T, Nuotio I, Nammas W, Grönberg T, Karmi A, Ylitalo A, Airaksinen KE.

Ann Med. 2015 Jun;47(4):341-5. doi: 10.3109/07853890.2015.1031821. Epub 2015 May 6.

PMID:
25943162
48.

Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study.

Lehto J, Gunn J, Karjalainen P, Airaksinen J, Kiviniemi T.

J Thorac Cardiovasc Surg. 2015 May;149(5):1324-9. doi: 10.1016/j.jtcvs.2015.01.031. Epub 2015 Jan 21.

49.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

Kiviniemi T, Airaksinen KE, Rubboli A, Biancari F, Valencia J, Lip GY, Karjalainen PP, Weber M, Laine M, Kirchhof P, Schlitt A; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group.

Int J Cardiol. 2015 Mar 15;183:105-10. doi: 10.1016/j.ijcard.2015.01.056. Epub 2015 Jan 27.

PMID:
25662060
50.

Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

Jalkanen J, Yegutkin GG, Hollmén M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H.

Circ Res. 2015 Mar 27;116(7):1206-15. doi: 10.1161/CIRCRESAHA.116.305715. Epub 2015 Feb 2.

PMID:
25645301

Supplemental Content

Loading ...
Support Center